GenomOncology said it will integrate Pacific Biosciences’ HiFi whole-genome sequencing secondary analysis pipeline into its Pathology Workbench reporting platform. The stated goal is to translate long-read WGS outputs into clinician-ready reports with quality control, variant interpretation, evidence curation, and report generation. The workflow integration targets an operational challenge in long-read sequencing deployments: moving from instrument outputs to standardized clinical reporting that accounts for tumor type and clinical context. GenomOncology said the system supports tailoring report programs for specific tumor types, myeloid-focused panels, and reimbursement requirements. If adopted broadly, the combined pipeline could reduce heterogeneity across laboratories using long-read WGS, particularly for oncology indications where variant interpretation can be the limiting step rather than sequencing throughput.